top of page

Developing Conformationally Stabilized Prefusion Subunit Vaccines
Locked immunogens best protect against infectious pathogens

Anchor 1
body1.png

Calder is a nano-scale, molecular engineering company that is applying its platform technology to engineer and develop novel vaccines that allow billions of people to stay healthy.

 

We're developing safe, effective, durable, and tolerable vaccines that protect against RSV, all strains of seasonal and pandemic influenza, and other harmful, viral infections.

Calder has developed its sophisticated & proprietary 3D-Vaxlock® technology that engineers site-specific, covalent crosslinks into proteins and creates subunit vaccine immunogens that elicit the most protective immune responses against viral pathogens by locking them in their most potent 3D shape.

pref3_edited.png

We focus on commercial opportunities with mitigated clinical risk that also address global health issues caused by viral infection.

Anchor 3
Screenshot 2023-01-26 at 8.57.35 PM.png
Anchor 2
Caldercircle-mini-icon-plusuniversal_edi

Subunit Vaccine

Development

State-of-the-Art

Technology

Scientific Journal

Publication

​

Immunogen Locking

Platform

 Novel Manufacturing

Economics

Industry

Leadership

Research

Partnerships

Safety & Efficacy

Testing

NY

Laboratory

Anchor 4
bottom of page